Abstract Details

Title An Indirect Comparison of Selected Adjunctive Treatments for Refractory Partial Onset Seizures (POS): Does Evidence Matter?

Topic Epilepsy/Clinical Neurophysiology (EEG)

Presentation(s) (-)

Poster/Presentation
Number 060

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Jeremy D. Slater, MD, FAAN (Stratus) PRESENTER	Dr. Slater has received personal compensation for serving as an employee of Stratus. Dr. Slater has stock in Zeto LLC.
Steve Chung, MD, FAAN (Banner University Medical Center)	The institution of Dr. Chung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ucb pharma. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life sciences. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for ucb. Dr. Chung has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Life sciences. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for sunovion.
	No disclosure on file
Mei-Sheng Duh, MPH, ScD	No disclosure on file
	No disclosure on file
Carolyn McMicken, PsyD (Neurocrine Biosciences)	No disclosure on file
Adam Ziemann, MD, PhD (Eli Lilly)	Dr. Ziemann has received personal compensation for serving as an employee of AbbVie. Dr. Ziemann has received stock or an ownership interest from AbbVie.
Jouko I. Isojarvi, MD, PhD (Lundbeck)	No disclosure on file

��ɫ��